STERIS plc (STE) · Insider trading
What STERIS's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$9.83M
7 insiders, 13% under a plan
Net, 12 months
−$9.83M
bought less sold
Latest filing
2026-10-05
filings read to 2026-10-19
Who traded, two years
| Insider | Bought | Sold | Trades | Last trade | Holds after |
|---|---|---|---|---|---|
| Carestio Daniel ADirector, President and CEO | – | $5.26M | 6 | 2026-06-05 | 63,647 |
| Zangerle John AdamSr. VP, Gen Counsel, and Sec. | – | $4.75M | 4 | 2026-06-15 | 35,259 |
| Majors Cary LSVP and President, Healthcare | – | $3.57M | 3 | 2025-05-20 | 15,953 |
| Tamaro RenatoV.P. & Corporate Treasurer | – | $2.10M | 4 | 2025-11-18 | 7,407 |
| Sohi MohsenDirector | – | $1.95M | 2 | 2026-08-12 | 24,305 |
| Burton Karen LVP & CAO | – | $1.91M | 1 | 2025-08-11 | 5,994 |
| Feldmann Cynthia LDirector | – | $1.58M | 2 | 2026-03-05 | 705 |
| Madsen JuliaSr. VP and GM, Life Sciences | – | $1.31M | 2 | 2025-11-21 | 10,710 |
| Breeden Richard CDirector | – | $310,284 | 1 | 2026-06-02 | 38,964 |
Open-market purchases and sales
Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Holds after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-12 | Sohi MohsenDirector | Sale | 4,058 | 235.78 | $956,795 | 24,305 | Form 4 |
| 2026-06-15 | Zangerle John AdamSr. VP, Gen Counsel, and Sec. | Saleplan | 1,419 | 209.28 | $296,968 | 35,259 | Form 4 |
| 2026-06-05 | Carestio Daniel ADirector, President and CEO | Saleplan | 1,374 | 212.00 | $291,288 | 63,647 | Form 4 |
| 2026-06-04 | Carestio Daniel ADirector, President and CEO | Saleplan | 3,054 | 214.64 | $655,511 | 65,021 | Form 4 |
| 2026-06-02 | Breeden Richard CDirector | Sale | 1,481 | 209.51 | $310,284 | 38,964 | Form 4 |
| 2026-03-05 | Feldmann Cynthia LDirector | Sale | 3,098 | 237.21 | $734,877 | 705 | Form 4 |
| 2025-11-21 | Madsen JuliaSr. VP and GM, Life Sciences | Sale | 2,872 | 262.00 | $752,464 | 10,710 | Form 4 |
| 2025-11-21 | Madsen JuliaSr. VP and GM, Life Sciences | Sale | 2,136 | 262.00 | $559,632 | 10,710 | Form 4 |
| 2025-11-18 | Tamaro RenatoV.P. & Corporate Treasurer | Sale | 3,324 | 257.43 | $855,697 | 7,407 | Form 4 |
| 2025-11-18 | Tamaro RenatoV.P. & Corporate Treasurer | Sale | 212 | 258.03 | $54,702 | 7,195 | Form 4 |
| 2025-11-18 | Tamaro RenatoV.P. & Corporate Treasurer | Sale | 1,500 | 257.76 | $386,640 | 5,695 | Form 4 |
| 2025-11-11 | Zangerle John AdamSr. VP, Gen Counsel, and Sec. | Sale | 15,000 | 265.14 | $3.98M | 33,669 | Form 4 |
| 2025-10-06 | Carestio Daniel ADirector, President and CEO | Saleplan | 159 | 241.82 | $38,449 | 51,096 | Form 4 |
| 2025-08-20 | Tamaro RenatoV.P. & Corporate Treasurer | Sale | 3,204 | 249.24 | $798,565 | 7,221 | Form 4 |
| 2025-08-11 | Burton Karen LVP & CAO | Sale | 7,900 | 241.73 | $1.91M | 5,994 | Form 4 |
| 2025-08-11 | Feldmann Cynthia LDirector | Sale | 3,495 | 241.56 | $844,252 | 705 | Form 4 |
| 2025-08-11 | Sohi MohsenDirector | Sale | 4,110 | 241.96 | $994,456 | 22,361 | Form 4 |
| 2025-06-13 | Zangerle John AdamSr. VP, Gen Counsel, and Sec. | Saleplan | 330 | 240.63 | $79,408 | 35,408 | Form 4 |
| 2025-06-13 | Zangerle John AdamSr. VP, Gen Counsel, and Sec. | Saleplan | 1,648 | 241.61 | $398,173 | 33,760 | Form 4 |
| 2025-06-05 | Carestio Daniel ADirector, President and CEO | Saleplan | 7,520 | 241.85 | $1.82M | 61,491 | Form 4 |
| 2025-06-05 | Carestio Daniel ADirector, President and CEO | Saleplan | 4,980 | 242.67 | $1.21M | 56,511 | Form 4 |
| 2025-06-05 | Carestio Daniel ADirector, President and CEO | Saleplan | 5,126 | 243.49 | $1.25M | 51,385 | Form 4 |
| 2025-05-20 | Majors Cary LSVP and President, Healthcare | Sale | 8,247 | 249.73 | $2.06M | 15,953 | Form 4 |
| 2025-05-20 | Majors Cary LSVP and President, Healthcare | Sale | 4,581 | 250.71 | $1.15M | 11,372 | Form 4 |
| 2024-11-25 | Majors Cary LSVP and President, Healthcare | Sale | 1,682 | 217.32 | $365,532 | 11,372 | Form 4 |
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
70 × shares withheld for tax20 × grant or award15 × option exercise
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-10-01 | Burton Karen LSr. Vice Pres., CFO | Shares withheld for tax F | −228 | – | 12,956 | Form 4 |
| 2026-08-12 | Sohi MohsenDirector | Option exercise M | +4,058 | 86.23 | 28,363 | Form 4 |
| 2026-07-01 | Sohi MohsenDirector | Option exercise M | +3,781 | 71.40 | 26,142 | Form 4 |
| 2026-07-01 | Sohi MohsenDirector | Shares withheld for tax F | −1,837 | 212.30 | 24,305 | Form 4 |
| 2026-06-04 | Burton Karen LSr. Vice Pres., CFO | Shares withheld for tax F | −90 | 212.24 | 13,184 | Form 4 |
| 2026-06-04 | Carestio Daniel ADirector, President and CEO | Shares withheld for tax F | −1,889 | 212.24 | 68,075 | Form 4 |
| 2026-06-04 | Fraser Mary ClareSVP & Chief HRO | Shares withheld for tax F | −600 | 212.24 | 13,716 | Form 4 |
| 2026-06-04 | Kohler Kenneth ESVP & GM, AST | Shares withheld for tax F | −150 | 212.24 | 11,332 | Form 4 |
| 2026-06-04 | Madsen JuliaSr. VP and GM, Life Sciences | Shares withheld for tax F | −195 | 212.24 | 12,257 | Form 4 |
| 2026-06-04 | Tamaro RenatoV.P. & Corporate Treasurer | Shares withheld for tax F | −65 | 212.24 | 6,194 | Form 4 |
| 2026-06-04 | Zangerle John AdamSr. VP, Gen Counsel, and Sec. | Shares withheld for tax F | −401 | 212.24 | 36,678 | Form 4 |
| 2026-06-03 | Burton Karen LSr. Vice Pres., CFO | Shares withheld for tax F | −190 | 210.19 | 13,274 | Form 4 |
| 2026-06-03 | Carestio Daniel ADirector, President and CEO | Shares withheld for tax F | −2,619 | 210.19 | 69,964 | Form 4 |
| 2026-06-03 | Fraser Mary ClareSVP & Chief HRO | Shares withheld for tax F | −311 | 210.19 | 14,316 | Form 4 |
| 2026-06-03 | Kohler Kenneth ESVP & GM, AST | Shares withheld for tax F | −184 | 210.19 | 11,482 | Form 4 |
| 2026-06-03 | Madsen JuliaSr. VP and GM, Life Sciences | Shares withheld for tax F | −239 | 210.19 | 12,452 | Form 4 |
| 2026-06-03 | Tamaro RenatoV.P. & Corporate Treasurer | Shares withheld for tax F | −64 | 210.19 | 6,259 | Form 4 |
| 2026-06-03 | Zangerle John AdamSr. VP, Gen Counsel, and Sec. | Shares withheld for tax F | −365 | 210.19 | 37,079 | Form 4 |
| 2026-06-02 | Breeden Richard CDirector | Option exercise M | +3,781 | 71.40 | 40,445 | Form 4 |
| 2026-06-02 | Burton Karen LSr. Vice Pres., CFO | Grant or award A | +5,325 | – | 13,530 | Form 4 |
| 2026-06-02 | Burton Karen LSr. Vice Pres., CFO | Option exercise M | −66 | 209.76 | 13,464 | Form 4 |
| 2026-06-02 | Carestio Daniel ADirector, President and CEO | Grant or award A | +23,736 | – | 73,578 | Form 4 |
| 2026-06-02 | Carestio Daniel ADirector, President and CEO | Shares withheld for tax F | −995 | 209.76 | 72,583 | Form 4 |
| 2026-06-02 | Fraser Mary ClareSVP & Chief HRO | Grant or award A | +3,009 | – | 15,218 | Form 4 |
| 2026-06-02 | Fraser Mary ClareSVP & Chief HRO | Shares withheld for tax F | −591 | 209.76 | 14,627 | Form 4 |
| 2026-06-02 | Kohler Kenneth ESVP & GM, AST | Grant or award A | +2,199 | – | 11,732 | Form 4 |
| 2026-06-02 | Kohler Kenneth ESVP & GM, AST | Shares withheld for tax F | −66 | 209.76 | 11,666 | Form 4 |
| 2026-06-02 | Madsen JuliaSr. VP and GM, Life Sciences | Grant or award A | +2,316 | – | 12,818 | Form 4 |
| 2026-06-02 | Madsen JuliaSr. VP and GM, Life Sciences | Shares withheld for tax F | −127 | 209.76 | 12,691 | Form 4 |
| 2026-06-02 | Majors Cary LSVP and President, Healthcare | Grant or award A | +4,746 | – | 17,405 | Form 4 |
| 2026-06-02 | Majors Cary LSVP and President, Healthcare | Shares withheld for tax F | −67 | 209.76 | 17,338 | Form 4 |
| 2026-06-02 | McGowan LindseyVP, Chf. Comp. & Quality Offc. | Grant or award A | +1,155 | – | 5,985 | Form 4 |
| 2026-06-02 | McGowan LindseyVP, Chf. Comp. & Quality Offc. | Shares withheld for tax F | −329 | 209.76 | 5,656 | Form 4 |
| 2026-06-02 | Tamaro RenatoV.P. & Corporate Treasurer | Grant or award A | +750 | – | 6,364 | Form 4 |
| 2026-06-02 | Tamaro RenatoV.P. & Corporate Treasurer | Shares withheld for tax F | −41 | 209.76 | 6,323 | Form 4 |
| 2026-06-02 | Zangerle John AdamSr. VP, Gen Counsel, and Sec. | Grant or award A | +4,359 | – | 37,691 | Form 4 |
| 2026-06-02 | Zangerle John AdamSr. VP, Gen Counsel, and Sec. | Shares withheld for tax F | −247 | 209.76 | 37,444 | Form 4 |
| 2026-06-01 | Burton Karen LSr. Vice Pres., CFO | Shares withheld for tax F | −99 | – | 8,205 | Form 4 |
| 2026-06-01 | Carestio Daniel ADirector, President and CEO | Shares withheld for tax F | −1,254 | – | 49,842 | Form 4 |
| 2026-06-01 | Fraser Mary ClareSVP & Chief HRO | Shares withheld for tax F | −673 | – | 12,209 | Form 4 |
| 2026-06-01 | Kohler Kenneth ESVP & GM, AST | Shares withheld for tax F | −109 | – | 9,533 | Form 4 |
| 2026-06-01 | Madsen JuliaSr. VP and GM, Life Sciences | Shares withheld for tax F | −208 | – | 10,502 | Form 4 |
| 2026-06-01 | Majors Cary LSVP and President, Healthcare | Shares withheld for tax F | −768 | – | 12,659 | Form 4 |
| 2026-06-01 | McGowan LindseyVP, Chf. Comp. & Quality Offc. | Shares withheld for tax F | −198 | – | 4,830 | Form 4 |
| 2026-06-01 | Tamaro RenatoV.P. & Corporate Treasurer | Shares withheld for tax F | −81 | – | 5,614 | Form 4 |
| 2026-06-01 | Zangerle John AdamSr. VP, Gen Counsel, and Sec. | Shares withheld for tax F | −337 | – | 33,332 | Form 4 |
| 2026-03-05 | Feldmann Cynthia LDirector | Option exercise M | +3,098 | 152.32 | 3,803 | Form 4 |
| 2026-01-02 | McGowan LindseyVP, Chf. Comp. & Quality Offc. | Grant or award A | +798 | – | 5,028 | Form 4 |
| 2025-11-21 | Madsen JuliaSr. VP and GM, Life Sciences | Option exercise M | +2,872 | 114.22 | 13,582 | Form 4 |
| 2025-11-21 | Madsen JuliaSr. VP and GM, Life Sciences | Option exercise M | +2,136 | 147.05 | 12,846 | Form 4 |
| 2025-11-18 | Tamaro RenatoV.P. & Corporate Treasurer | Option exercise M | +3,536 | 182.22 | 10,731 | Form 4 |
| 2025-11-11 | Zangerle John AdamSr. VP, Gen Counsel, and Sec. | Option exercise M | +15,000 | 69.72 | 48,669 | Form 4 |
| 2025-10-01 | Carestio Daniel ADirector, President and CEO | Shares withheld for tax F | −130 | – | 51,255 | Form 4 |
| 2025-10-01 | Burton Karen LSr. Vice Pres., CFO | Shares withheld for tax F | −39 | – | 5,955 | Form 4 |
| 2025-10-01 | Burton Karen LSr. Vice Pres., CFO | Grant or award A | +2,349 | – | 8,304 | Form 4 |
| 2025-10-01 | Fraser Mary ClareSVP & Chief HRO | Shares withheld for tax F | −207 | – | 12,882 | Form 4 |
| 2025-10-01 | Madsen JuliaSr. VP and GM, Life Sciences | Shares withheld for tax F | −52 | – | 10,710 | Form 4 |
| 2025-10-01 | Majors Cary LSVP and President, Healthcare | Shares withheld for tax F | −303 | – | 13,427 | Form 4 |
| 2025-10-01 | Tamaro RenatoV.P. & Corporate Treasurer | Shares withheld for tax F | −26 | – | 7,195 | Form 4 |
| 2025-10-01 | Zangerle John AdamSr. VP, Gen Counsel, and Sec. | Shares withheld for tax F | −91 | – | 33,669 | Form 4 |
| 2025-08-20 | Tamaro RenatoV.P. & Corporate Treasurer | Option exercise M | +3,204 | 147.05 | 10,425 | Form 4 |
| 2025-08-13 | Breeden Richard CDirector | Option exercise M | +4,110 | 64.05 | 36,664 | Form 4 |
| 2025-08-11 | Burton Karen LVP & CAO | Option exercise M | +7,900 | 114.22 | 13,894 | Form 4 |
| 2025-08-11 | Feldmann Cynthia LDirector | Option exercise M | +3,495 | – | 4,200 | Form 4 |
| 2025-08-11 | Sohi MohsenDirector | Option exercise M | +4,110 | 64.05 | 26,471 | Form 4 |
| 2025-06-04 | Burton Karen LVP & CAO | Shares withheld for tax F | −92 | 242.10 | 5,994 | Form 4 |
| 2025-06-04 | Carestio Daniel ADirector, President and CEO | Shares withheld for tax F | −1,921 | 242.10 | 69,011 | Form 4 |
| 2025-06-04 | Kohler Kenneth ESVP & GM, AST | Shares withheld for tax F | −154 | 242.10 | 6,776 | Form 4 |
| 2025-06-04 | Tamaro RenatoV.P. & Corporate Treasurer | Shares withheld for tax F | −66 | 242.10 | 7,221 | Form 4 |
| 2025-06-04 | Zangerle John AdamSr. VP, Gen Counsel, and Sec. | Shares withheld for tax F | −425 | 242.10 | 35,738 | Form 4 |
| 2025-06-04 | Madsen JuliaSr. VP and GM, Life Sciences | Shares withheld for tax F | −194 | 242.10 | 10,762 | Form 4 |
| 2025-06-04 | Tokich Michael JSr. Vice Pres., CFO | Shares withheld for tax F | −341 | 242.10 | 43,891 | Form 4 |
| 2025-06-03 | Burton Karen LVP & CAO | Grant or award A | +1,953 | – | 6,086 | Form 4 |
| 2025-06-03 | Carestio Daniel ADirector, President and CEO | Grant or award A | +17,811 | – | 70,932 | Form 4 |
| 2025-06-03 | Fraser Mary ClareSVP & Chief HRO | Grant or award A | +2,505 | – | 13,089 | Form 4 |
| 2025-06-03 | Tokich Michael JSr. Vice Pres., CFO | Grant or award A | +2,223 | – | 44,232 | Form 4 |
| 2025-06-03 | Madsen JuliaSr. VP and GM, Life Sciences | Grant or award A | +1,998 | – | 10,956 | Form 4 |
| 2025-06-03 | Zangerle John AdamSr. VP, Gen Counsel, and Sec. | Grant or award A | +3,756 | – | 36,163 | Form 4 |
| 2025-06-03 | Majors Cary LSVP and President, Healthcare | Grant or award A | +2,922 | – | 13,730 | Form 4 |
| 2025-06-03 | Tamaro RenatoV.P. & Corporate Treasurer | Grant or award A | +651 | – | 7,287 | Form 4 |
| 2025-06-03 | Kohler Kenneth ESVP & GM, AST | Grant or award A | +1,890 | – | 6,930 | Form 4 |
| 2025-06-02 | Burton Karen LVP & CAO | Shares withheld for tax F | −102 | 242.08 | 4,260 | Form 4 |
| 2025-06-02 | Burton Karen LVP & CAO | Shares withheld for tax F | −59 | 242.08 | 4,201 | Form 4 |
| 2025-06-02 | Burton Karen LVP & CAO | Shares withheld for tax F | −68 | 242.08 | 4,133 | Form 4 |
| 2025-06-02 | Carestio Daniel ADirector, President and CEO | Shares withheld for tax F | −1,905 | 242.08 | 54,281 | Form 4 |
| 2025-06-02 | Carestio Daniel ADirector, President and CEO | Shares withheld for tax F | −452 | 242.08 | 53,829 | Form 4 |
| 2025-06-02 | Carestio Daniel ADirector, President and CEO | Shares withheld for tax F | −708 | 242.08 | 53,121 | Form 4 |
| 2025-06-02 | Fraser Mary ClareSVP & Chief HRO | Shares withheld for tax F | −548 | 242.08 | 10,584 | Form 4 |
| 2025-06-02 | Kohler Kenneth ESVP & GM, AST | Shares withheld for tax F | −112 | 242.08 | 5,147 | Form 4 |
| 2025-06-02 | Kohler Kenneth ESVP & GM, AST | Shares withheld for tax F | −39 | 242.08 | 5,108 | Form 4 |
| 2025-06-02 | Kohler Kenneth ESVP & GM, AST | Shares withheld for tax F | −68 | 242.08 | 5,040 | Form 4 |
| 2025-06-02 | Madsen JuliaSr. VP and GM, Life Sciences | Shares withheld for tax F | −207 | 242.08 | 9,214 | Form 4 |
| 2025-06-02 | Madsen JuliaSr. VP and GM, Life Sciences | Shares withheld for tax F | −129 | 242.08 | 9,085 | Form 4 |
| 2025-06-02 | Madsen JuliaSr. VP and GM, Life Sciences | Shares withheld for tax F | −127 | 242.08 | 8,958 | Form 4 |
| 2025-06-02 | Majors Cary LSVP and President, Healthcare | Shares withheld for tax F | −564 | 242.08 | 10,808 | Form 4 |
| 2025-06-02 | Tamaro RenatoV.P. & Corporate Treasurer | Shares withheld for tax F | −72 | 242.08 | 6,729 | Form 4 |
| 2025-06-02 | Tamaro RenatoV.P. & Corporate Treasurer | Shares withheld for tax F | −51 | 242.08 | 6,678 | Form 4 |
| 2025-06-02 | Tamaro RenatoV.P. & Corporate Treasurer | Shares withheld for tax F | −42 | 242.08 | 6,636 | Form 4 |
| 2025-06-02 | Tokich Michael JSr. Vice Pres., CFO | Shares withheld for tax F | −386 | 242.08 | 42,350 | Form 4 |
| 2025-06-02 | Tokich Michael JSr. Vice Pres., CFO | Shares withheld for tax F | −172 | 242.08 | 42,178 | Form 4 |
| 2025-06-02 | Tokich Michael JSr. Vice Pres., CFO | Shares withheld for tax F | −169 | 242.08 | 42,009 | Form 4 |
| 2025-06-02 | Zangerle John AdamSr. VP, Gen Counsel, and Sec. | Shares withheld for tax F | −346 | 242.08 | 32,905 | Form 4 |
| 2025-06-02 | Zangerle John AdamSr. VP, Gen Counsel, and Sec. | Shares withheld for tax F | −245 | 242.08 | 32,660 | Form 4 |
| 2025-06-02 | Zangerle John AdamSr. VP, Gen Counsel, and Sec. | Shares withheld for tax F | −253 | 242.08 | 32,407 | Form 4 |
| 2025-05-20 | Majors Cary LSVP and President, Healthcare | Option exercise M | +12,828 | 147.05 | 24,200 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.